Skip to main content
OpenTrials

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

458 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

NCT02751996

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Spring Bank Pharma Research site Calgary, Alberta, Canada
  • Spring Bank Pharma Research site Vancouver, British Columbia, Canada
  • Spring Bank Pharma Research Site London, Ontario, Canada
  • Spring Bank Pharma Research site Toronto, Ontario, Canada
View all 17 locations
View Trial Details
Completed

Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria

NCT04264312

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • Xicheng District Center for Disease Prevention and Control Beijing, Beijing Municipality, China
  • Huairou District Center for Disease Prevention and Control Beijing, Beijing Municipality, China
  • Daxing District Center for Disease Prevention and Control Beijing, Beijing Municipality, China
  • Chaoyang District Center for Disease Control and Prevention Beijing, Beijing Municipality, China
View Trial Details
Completed

A Study to Evaluate Persistence of Hepatitis B Antibodies, Immunogenicity and Safety of Engerix™-B Kinder Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa During Infancy

NCT02798952

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Stuttgart, Baden-Wurttemberg, Germany
  • GSK Investigational Site Tuttlingen, Baden-Wurttemberg, Germany
View all 14 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02853929

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +37 more
Locations
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Calgary, Alberta, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View all 29 locations
View Trial Details
Completed

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

NCT00352963

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations
  • GSK Investigational Site Alcorcón, Spain
  • GSK Investigational Site Almeira, Spain
  • GSK Investigational Site Badalona, Spain
  • GSK Investigational Site Barcelona, Spain
View all 22 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

NCT00970307

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Bydgoszcz, Poland
  • GSK Investigational Site Dębica, Poland
  • GSK Investigational Site Krakow, Poland
  • GSK Investigational Site Krakow, Poland
View Trial Details
Completed

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

NCT00463437

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +38 more
Locations
  • GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Bretten, Baden-Wurttemberg, Germany
  • GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
View all 63 locations
View Trial Details

Related conditions